Quest Diagnostics Rolls Out New Gene Expression Test for Melanoma risk Assessment
Quest Diagnostics is rolling out MelaNodal Predict, a predictive gene expression test that can help personalize treatment decisions melanoma patients. Dermatologists and other providers nationwide may begin ordering the test today from Quest Diagnostics, as well as through Dermpath Diagnostics, Quest’s subspecialty pathology business. MelaNodal Predict is based on technology developed by SkylineDx and the Mayo […]